New Delhi: Branded and patented pharmaceutical imports will face a 100% import duty in the United States from October 1, 2025, President Donald Trump announced. However, companies that have already started building drug manufacturing plants in America will be spared.

According to Trump, pharma firms that have “broken ground” or are “under construction” with new U.S. drug production facilities will not fall under the tariff plan. “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started,” he clarified.

The announcement is part of a broader tariff package. Imports of heavy trucks will attract a 25% duty, kitchen cabinets and bathroom vanities 50%, and upholstered furniture 30%. The pharmaceutical levy, however, has drawn the most attention because o

See Full Page